These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 9730152)

  • 61. Induction chemotherapy with docetaxel, 5-FU and CDDP (DFP) for advanced gastric cancer.
    Yamamoto K; Fujiwara Y; Nishida T; Takiguchi S; Nakajima K; Miyata H; Yamasaki M; Mori M; Doki Y
    Anticancer Res; 2009 Oct; 29(10):4211-5. PubMed ID: 19846975
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Phase II trial of postoperative adjuvant intraperitoneal cisplatin and fluorouracil and systemic fluorouracil chemotherapy in patients with resected gastric cancer.
    Atiq OT; Kelsen DP; Shiu MH; Saltz L; Tong W; Niedzwiecki D; Trochanowski B; Lin S; Toomasi F; Brennan M
    J Clin Oncol; 1993 Mar; 11(3):425-33. PubMed ID: 8445416
    [TBL] [Abstract][Full Text] [Related]  

  • 63. [A cooperative study on concomitant with low-dose divided administration of cisplatin (CDDP) and sustained drip infusion of 5-fluorouracil (5-FU) for unresectable advanced gastric cancer. Osaka Cisplatin Gastric Cancer Study Group].
    Narahara H; Otani T; Iwanaga T; Okajima K; Katsu K; Sowa M; Kobayashi K; Yasutomi M; Okuno M; Takami M; Ishida T; Yasutake K; Yamamoto H; Taguchi T
    Gan To Kagaku Ryoho; 1998 Jun; 25(7):1021-6. PubMed ID: 9644317
    [TBL] [Abstract][Full Text] [Related]  

  • 64. [Interim report of JFMC study no. 23--phase III randomized clinical trial on the effectiveness of low-dose cisplatin plus 5-FU as a postoperative adjuvant chemotherapy for advanced gastric cancer].
    Saji S; Toge T; Kurosu Y; Hirata K; Gochi A; Tominaga S; Inokuchi K
    Gan To Kagaku Ryoho; 2002 Dec; 29(13):2499-507. PubMed ID: 12506472
    [TBL] [Abstract][Full Text] [Related]  

  • 65. [Two cases of pseudomyxoma peritonei that responded to intraperitoneal administrations of a combined CDDP, 5-FU and MMC therapy].
    Sasaki A; Terashima M; Okamoto K; Ikeda K; Takagane A; Takiyama I; Kuboi M; Sasaki N; Saito K
    Gan To Kagaku Ryoho; 1996 Sep; 23(11):1571-4. PubMed ID: 8854808
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Chemotherapy of carcinomas of the digestive tract.
    Gisselbrecht C; Belpomme D; Mignot L; Marty M; Mathé G; Boiron M
    Recent Results Cancer Res; 1982; 80():296-302. PubMed ID: 6799999
    [TBL] [Abstract][Full Text] [Related]  

  • 67. [Usefulness of continuous venous daily chemotherapy of 5-fluorouracil and low-dose cisplatin for patients undergoing noncurative surgery].
    Hoshino K; Ono K; Kimura O; Kawaguchi H; Fukui H; Ikeda M
    Gan To Kagaku Ryoho; 1997 Nov; 24(14):2105-10. PubMed ID: 9388520
    [TBL] [Abstract][Full Text] [Related]  

  • 68. [Neoadjuvant chemotherapy in high-grade advanced gastric cancer with protracted infusional 5-fluorouracil and consecutive low-dose cisplatin].
    Kondo K; Murase M; Yokoyama Y; Kato J; Hibi K; Kasai Y; Akiyama S; Ito K; Takagi H
    Gan To Kagaku Ryoho; 1996 Sep; 23(10):1299-303. PubMed ID: 8831742
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Biweekly oxaliplatin, fluorouracil and leucovorin versus cisplatin, fluorouracil and leucovorin in patients with advanced gastric cancer.
    Popov I; Radosevic-Jelic L; Jezdic S; Milovic M; Borojevic N; Stojanovic S; Stankovic V; Josifovski T; Kezic I
    J BUON; 2008; 13(4):505-11. PubMed ID: 19145671
    [TBL] [Abstract][Full Text] [Related]  

  • 70. [Chemotherapy with consecutive low-dose CDDP combined with 5-FU for gynecologic malignancies].
    Shimizu Y; Hasumi K
    Gan To Kagaku Ryoho; 1999 Oct; 26(11):1564-74. PubMed ID: 10553414
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Postoperative chemoradiotherapy in gastric cancer -- a Phase I/II dose-finding study of radiotherapy with dose escalation of cisplatin and capecitabine chemotherapy.
    Jansen EP; Boot H; Dubbelman R; Bartelink H; Cats A; Verheij M
    Br J Cancer; 2007 Sep; 97(6):712-6. PubMed ID: 17848909
    [TBL] [Abstract][Full Text] [Related]  

  • 72. [A case of rectal cancer with multiple liver and peritoneal metastases that responded dramatically to low-dose 5-FU plus LV and CDDP combination chemotherapy].
    Nikkuni K; Nagahashi M; Makino S; Nishimura A; Kawachi Y; Shimizu T
    Gan To Kagaku Ryoho; 2004 Oct; 31(10):1591-4. PubMed ID: 15508457
    [TBL] [Abstract][Full Text] [Related]  

  • 73. [Interim report of JFMTC study no. 20 on the effectiveness of high dose CDDP plus 5-FU regimen as an adjuvant therapy for far-advanced cancer of the stomach].
    Toge T; Fujita M; Hirata K; Kunii Y; Kitamura M; Nagawa H; Kubota T; Wakasugi J; Kasai Y; Takahashi Y; Furukawa H; Takao T; Kaibara N; Takashima S; Kakegawa T; Tomita M; Nose Y
    Gan To Kagaku Ryoho; 2000 Mar; 27(3):395-403. PubMed ID: 10740633
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Adjuvant postoperative fluorouracil-modulated chemotherapy combined with pelvic radiation therapy for rectal cancer: initial results of intergroup 0114.
    Tepper JE; O'Connell MJ; Petroni GR; Hollis D; Cooke E; Benson AB; Cummings B; Gunderson LL; Macdonald JS; Martenson JA
    J Clin Oncol; 1997 May; 15(5):2030-9. PubMed ID: 9164215
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Salvage chemotherapy with PEM and long-CF regimen in CDDP refractory advanced head and neck cancer.
    Kohno N; Ichikawa G; Shirasaka T; Inuyama Y; Kawaida M; Ohnuma T
    Gan To Kagaku Ryoho; 1995 Aug; 22 Suppl 3():209-14. PubMed ID: 7661582
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Phase I/II study of divided-dose docetaxel, cisplatin and fluorouracil for patients with recurrent or metastatic squamous cell carcinoma of the esophagus.
    Ojima T; Nakamori M; Nakamura M; Katsuda M; Hayata K; Matsumura S; Iwahashi M; Yamaue H
    Dis Esophagus; 2017 Feb; 30(2):1-7. PubMed ID: 26725778
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Phase I Study of Docetaxel, Cisplatin, and 5-Fluorouracil Chemoradiotherapy for Local or Metastatic Esophageal Cancer.
    Iwasaki K; Osaka Y; Tachibana S; Suda T; Ota Y; Hoshino S; Tsuchida A
    Anticancer Res; 2016 Mar; 36(3):987-94. PubMed ID: 26976988
    [TBL] [Abstract][Full Text] [Related]  

  • 78. [Combination chemotherapy with 5-FU and CDDP or CDDP analog for head and neck cancer].
    Fujii M; Ohno Y; Tokumaru Y; Imanishi Y; Kanke M
    Gan To Kagaku Ryoho; 1996 Nov; 23(13):1740-6. PubMed ID: 8937483
    [TBL] [Abstract][Full Text] [Related]  

  • 79. [Study of serum CDDP concentrations in patients with advanced or recurrent adeno-or squamous cell carcinoma under combination chemotherapy of 5-FU (CIV) and low-dose CDDP (IV)].
    Yagihashi A; Sasaki K; Hirata K; Yamamitsu S
    Gan To Kagaku Ryoho; 1996 Jan; 23(1):63-7. PubMed ID: 8546471
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Sequence-dependence of cisplatin and 5-fluorouracil in advanced and recurrent gastric cancer.
    Koizumi W; Kurihara M; Hasegawa K; Chonan A; Kubo Y; Maekawa R; Iwasaki R; Sasai T; Fukuyama Y; Ishikawa K; Miyoshi K; Yasutake K; Hayakawa M
    Oncol Rep; 2004 Sep; 12(3):557-61. PubMed ID: 15289837
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.